Financials

News Ideas Discussions Technicals Seasonals

PER fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PERCHERON THERAPEUTICS LIMITED operating, investing, and financing activities

PER free cash flow for H1 25 is -8.49 M AUD. For 2024, PER free cash flow was -10.12 M AUD and operating cash flow was -10.12 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—